May 14, 2019 - Lilly's (LLY) Cyramza gets FDA approval to treat AFP-high hepatocellular carcinoma (HCC), a common form of liver cancer. FDA removes boxed warning from label.
May 13, 2019 - Top Stock Reports for Amgen, Altria & Booking Holdings
May 05, 2019 - Teva's turnaround won't kick into high gear anytime soon.
May 03, 2019 - Teva Pharmaceutical (TEVA) beats estimates for earnings but misses the same for sales. Blockbuster drug Copaxone sales continue to erode amid generic competition.
May 01, 2019 - Key highlights of the past week are earnings releases by most leading biotech entities.
May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
Apr 30, 2019 - Amgen Inc. (NASDAQ:AMGN) Q1 2019 Earnings Conference Call April 30, 2019 05:00 PM ET Company Participants Arvind Sood - VP of IR Bob Bradway - Chairman and CEO David Meline - CFO Murdo Gordon - Head o
Apr 30, 2019 - AMGN earnings call for the period ending March 31, 2019.
Apr 30, 2019 - Eli Lilly's (LLY) earnings beat estimates in Q1. Stock falls in pre-market trading as the company lowers its full-year revenue forecast.
Apr 29, 2019 - Cigna's (CI) Q1 earnings should benefit from increase in revenues and membership.